Sign in

CIK 0001520262

  • Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981007018
Phone
+353 17728000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
  1. 4 Open-market sale SVP, Chief Financial Officer sold 35,000 shares at an average $20.00 ($699,918)
  2. 4 Open-market sale EVP R&D, Chief Medical Officer sold 28,920 shares at $19.72 ($570,288)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 1,292 shares (to pay taxes)
  11. 4 Shares withheld for taxes Director and CEO, Alkermes plc gave up 14,386 shares (to pay taxes)
  12. 4 Shares withheld for taxes SVP, Corp Dev., Alkermes, Inc. gave up 4,947 shares (to pay taxes)
  13. 4 Shares withheld for taxes EVP, Chief Operating Officer gave up 2,786 shares (to pay taxes)
  14. 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 5,086 shares (to pay taxes)
  15. 4 Shares withheld for taxes SVP, CLO, Alkermes, Inc. gave up 4,083 shares (to pay taxes)
  16. 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 2,790 shares (to pay taxes)
  17. 4 Shares withheld for taxes Director and CEO, Alkermes plc gave up 11,943 shares (to pay taxes)
  18. 4 Shares withheld for taxes SVP, Corp Dev., Alkermes, Inc. gave up 3,170 shares (to pay taxes)
  19. 4 Shares withheld for taxes EVP, Chief Operating Officer gave up 1,606 shares (to pay taxes)
  20. 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 1,172 shares (to pay taxes)

Page 18 of 67 · 1,323 filings